VICTORY CAPITAL MANAGEMENT INC
Position in PCRX — Pacira BioSciences, Inc.
CIK 1040188
San Antonio, TX
Position in PCRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,313,034
-$3,546,026 QoQ
Shares Held
235,090
-31.3% QoQ
Ownership
0.597%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in PCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026VICTORY CAPITAL MANAGEMENT INC holds $398,774,467 across 27 Drug Manufacturers - Specialty & Generic names. PCRX ranks #14 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
731,609 | $96,382,169 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,838,437 | $55,373,722 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
60,541 | $35,899,602 | |
| 4 | ZTS |
Zoetis Inc.
|
295,063 | $34,879,397 | |
| 5 | VTRS |
Viatris Inc
|
2,394,145 | $32,344,898 | |
| 6 | SUPN |
Supernus Pharmaceuticals, Inc.
|
502,406 | $25,969,366 | |
| 7 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
506,521 | $24,388,985 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
625,304 | $20,678,803 |
All Filings in PCRX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,313,034 | 235,090 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $8,859,060 | 342,313 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $7,379,703 | 286,368 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $5,302,071 | 221,844 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $5,157,741 | 207,555 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $1,785,090 | 94,750 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $1,839,531 | 122,228 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $2,507,351 | 87,639 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $2,158,276 | 73,863 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $2,212,129 | 65,564 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $2,107,317 | 68,687 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $2,810,229 | 70,133 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $2,765,530 | 67,766 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $2,493,317 | 64,577 | Shares | Sole | 2023-04-25 | |
| 2022-09-30 | $3,937,283 | 74,023 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $3,803,375 | 65,238 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $5,442,913 | 71,317 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $4,493,074 | 74,673 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $4,019,344 | 71,774 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $4,178,788 | 68,866 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $5,891,695 | 84,059 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $1,012,432 | 16,919 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $1,070,857 | 17,812 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $667,575 | 12,723 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $399,308 | 11,909 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||